Akron, OHNCT05650229Now EnrollingIRB Ready

Primary Mitochondrial Disease Clinical Trial in Akron, OH

Access cutting-edge primary mitochondrial disease treatment through this clinical trial at a research site in Akron. Study-provided care at no cost to qualified participants.

Sponsored by Abliva AB

Quick Self-Assessment

See if you qualify for this Akron location

Preparing your pre-screening questions...

Expert Care in Akron

Access primary mitochondrial disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary mitochondrial disease treatment provided free

Apply for This Akron Location

Check if you qualify for this primary mitochondrial disease clinical trial in Akron, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Akron

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Akron site if eligible
  4. 4Begin participation

About This Primary Mitochondrial Disease Study in Akron

The primary objective of the FALCON study is to evaluate the efficacy of KL1333 on selected disease manifestations of primary mitochondrial disease (PMD) following 48 weeks of treatment. This objective involves evaluating the efficacy of KL1333 versus placebo on fatigue symptoms and impacts on daily living as well as on functional lower extremity strength and endurance. Additionally, the study evaluates the safety and tolerability of KL1333.

Sponsor: Abliva AB

Who Can Participate

Inclusion Criteria

Age 18 years or older.
A confirmed PMD diagnosis caused by a known pathogenic gene mutation or deletion of the mitochondrial genome (category 6 of the International Classification of Inborn Metabolic Disorders \[ICIMD\])12 according to American College of Medical Genetics (ACMG)/Association of Molecular Pathology (AMP) criteria1, with multisystemic disease expressions, including: 1. m.3243A\>G associated MELAS-MIDD spectrum disorders, 2. single large scale mtDNA deletion associated KSS-CPEO spectrum disorders, 3. other multisystemic mtDNA-related disease (including MERRF).
Presence of chronic mitochondrial fatigue:
History of mitochondrial fatigue for at least 3 months prior to the Screening Visit AND
Presence of at least moderate level of fatigue, assessed by PROMIS® Fatigue PMD Short form raw score ≥ 27 at Screening and Baseline
Presence of mitochondrial myopathy defined as:
Myopathy (proximal muscle weakness), NMDAS Section III Clini

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Akron?

Yes, this clinical trial (NCT05650229) has an active research site in Akron, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Mitochondrial Disease Treatment Options in Akron, OH

If you're searching for primary mitochondrial disease treatment options in Akron, OH, this clinical trial (NCT05650229) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Akron research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary mitochondrial disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary mitochondrial disease clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Akron, OH

See all heart attack clinical trials recruiting in Akron — not just this study.

Browse Heart Attack Trials in Akron →

Browse More Trials by Condition

Heart Attack TrialsAnkylosing Spondylitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Akron?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Akron, OH